Scandinavian Real Heart AB (Publ) (HEART.ST)
SEK 12.54
(-2.79%)
SEK 12.54
(-2.79%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 8.24 Million SEK | 279.48% |
| 2022 | 2.17 Million SEK | -22.22% |
| 2021 | 2.79 Million SEK | -18.18% |
| 2020 | 3.41 Million SEK | -8.03% |
| 2019 | 3.71 Million SEK | -7.14% |
| 2018 | 4 Million SEK | 0.0% |
| 2017 | 4 Million SEK | 55.72% |
| 2016 | 2.56 Million SEK | 1074.29% |
| 2015 | 218.75 Thousand SEK | 191.67% |
| 2014 | 75 Thousand SEK | 0.0% |
| 2013 | - SEK | 0.0% |
| 2012 | - SEK | 0.0% |
| 2011 | - SEK | 0.0% |
| 2010 | - SEK | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 7.77 Million SEK | -5.75% |
| 2024 Q2 | 7.3 Million SEK | -6.1% |
| 2023 Q3 | 8.72 Million SEK | -5.16% |
| 2023 FY | 8.24 Million SEK | 279.48% |
| 2023 Q4 | 8.24 Million SEK | -5.44% |
| 2023 Q1 | 5.81 Million SEK | 167.66% |
| 2023 Q2 | 9.19 Million SEK | 58.08% |
| 2022 Q1 | 621.11 Thousand SEK | -77.78% |
| 2022 Q2 | 621.11 Thousand SEK | 0.0% |
| 2022 Q4 | 2.17 Million SEK | 250.0% |
| 2022 Q3 | 621.11 Thousand SEK | 0.0% |
| 2022 FY | 2.17 Million SEK | -22.22% |
| 2021 Q2 | 621.11 Thousand SEK | 0.0% |
| 2021 Q1 | 621.11 Thousand SEK | -81.82% |
| 2021 Q3 | 621.11 Thousand SEK | 0.0% |
| 2021 Q4 | 2.79 Million SEK | 350.0% |
| 2021 FY | 2.79 Million SEK | -18.18% |
| 2020 Q3 | 571.42 Thousand SEK | 0.0% |
| 2020 FY | 3.41 Million SEK | -8.03% |
| 2020 Q1 | 571.42 Thousand SEK | -84.62% |
| 2020 Q4 | 3.41 Million SEK | 497.83% |
| 2020 Q2 | 571.42 Thousand SEK | 0.0% |
| 2019 FY | 3.71 Million SEK | -7.14% |
| 2019 Q1 | 4 Million SEK | 0.0% |
| 2019 Q2 | 533.33 Thousand SEK | -86.67% |
| 2019 Q3 | 533.33 Thousand SEK | 0.0% |
| 2019 Q4 | 3.71 Million SEK | 596.43% |
| 2018 Q1 | - SEK | -100.0% |
| 2018 FY | 4 Million SEK | 0.0% |
| 2018 Q4 | 4 Million SEK | 0.0% |
| 2018 Q3 | - SEK | 0.0% |
| 2018 Q2 | - SEK | 0.0% |
| 2017 FY | 4 Million SEK | 55.72% |
| 2017 Q3 | - SEK | -100.0% |
| 2017 Q4 | 4 Million SEK | 0.0% |
| 2017 Q2 | 2.53 Million SEK | -0.74% |
| 2017 Q1 | 2.55 Million SEK | 0.0% |
| 2016 Q2 | 2.6 Million SEK | 0.0% |
| 2016 Q4 | - SEK | -100.0% |
| 2016 FY | 2.56 Million SEK | 1074.29% |
| 2016 Q3 | 2.58 Million SEK | -0.72% |
| 2015 Q2 | 181.25 Thousand SEK | -9.38% |
| 2015 FY | 218.75 Thousand SEK | 191.67% |
| 2015 Q4 | 218.75 Thousand SEK | 34.62% |
| 2015 Q3 | 162.5 Thousand SEK | -10.34% |
| 2015 Q1 | 200 Thousand SEK | 166.67% |
| 2014 Q4 | 75 Thousand SEK | 0.0% |
| 2014 FY | 75 Thousand SEK | 0.0% |
| 2013 FY | - SEK | 0.0% |
| 2012 FY | - SEK | 0.0% |
| 2011 FY | - SEK | 0.0% |
| 2010 FY | - SEK | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Acarix AB (publ) | - SEK | -Infinity% |
| ADDvise Group AB (publ) | 1.61 Billion SEK | 99.489% |
| ADDvise Group AB (publ) | 1.61 Billion SEK | 99.489% |
| Arcoma AB | 3.87 Million SEK | -113.003% |
| Bactiguard Holding AB (publ) | 233.09 Million SEK | 96.461% |
| BICO Group AB (publ) | 1.85 Billion SEK | 99.555% |
| Boule Diagnostics AB (publ) | 166.1 Million SEK | 95.033% |
| CellaVision AB (publ) | 64.7 Million SEK | 87.25% |
| Clinical Laserthermia Systems AB (publ) | 454 Thousand SEK | -1717.098% |
| Chordate Medical Holding AB (publ) | - SEK | -Infinity% |
| C-Rad AB (publ) | 1.8 Million SEK | -358.313% |
| Duearity AB (publ) | 10.58 Million SEK | 22.041% |
| Dignitana AB (publ) | 19.1 Million SEK | 56.817% |
| Episurf Medical AB (publ) | 5.2 Million SEK | -58.647% |
| Getinge AB (publ) | 8.07 Billion SEK | 99.898% |
| Iconovo AB (publ) | 7.72 Million SEK | -6.793% |
| Integrum AB (publ) | 6.42 Million SEK | -28.415% |
| Luxbright AB (publ) | 206.02 Thousand SEK | -3904.206% |
| Mentice AB (publ) | 9.55 Million SEK | 13.68% |
| OssDsign AB (publ) | 3.15 Million SEK | -161.893% |
| Paxman AB (publ) | 13.57 Million SEK | 39.207% |
| Promimic AB (publ) | - SEK | -Infinity% |
| Qlife Holding AB (publ) | 20.73 Million SEK | 60.206% |
| SciBase Holding AB (publ) | 6.79 Million SEK | -21.372% |
| ScandiDos AB (publ) | - SEK | -Infinity% |
| Sectra AB (publ) | 31.78 Million SEK | 74.048% |
| Sedana Medical AB (publ) | 4.3 Million SEK | -91.584% |
| Senzime AB (publ) | 11.46 Million SEK | 28.064% |
| SpectraCure AB (publ) | 6.71 Million SEK | -22.817% |
| Stille AB | 62.94 Million SEK | 86.893% |
| Vitrolife AB (publ) | 2.08 Billion SEK | 99.605% |
| Xvivo Perfusion AB (publ) | 31.43 Million SEK | 73.758% |